Thomas Cummings
About Thomas Cummings
Thomas Cummings is the Associate Director of Outsourcing and Nonclinical Operations at Alkermes in Waltham, MA, responsible for ensuring timely and high-quality deliverables from the Nonclinical Safety Evaluation organization.
Current Role at Alkermes
Thomas Cummings currently holds the position of Associate Director, Outsourcing and Nonclinical Operations at Alkermes in Waltham, Massachusetts. In his role, he is responsible for ensuring timely and high-quality deliverables from the Nonclinical Safety Evaluation organization. This involves working closely with toxicologists and external Contract Research Organizations (CROs) to implement nonclinical development plans for Alkermes’ drug candidates. He plays a vital role in defining the scope of nonclinical operations and implementing processes to achieve efficiencies.
Previous Role: Senior Scientist at Alkermes
Prior to his current role, Thomas Cummings served as a Senior Scientist in Nonclinical Safety Evaluation at Alkermes from 2018 to 2020. In this role, he focused on the safety evaluation of nonclinical candidates, contributing his expertise to the successful development of drug safety profiles.
Former Positions at Pfizer
Thomas Cummings has an extensive history with Pfizer, working there in various capacities over an 18-year period. He held the role of General Toxicology Study Monitor (Principal Scientist) from 2010 to 2018. Before that, he was an Outsourcing Professional from 2007 to 2010 and a Training Associate in Drug Safety Research and Development from 2000 to 2007.
Educational Background
Thomas Cummings obtained his Bachelor of Science degree in Animal Science from the University of Connecticut, where he studied from 1982 to 1986. This academic foundation has supported his extensive career in nonclinical safety and toxicology.